Decoding SIGLEC12 in Bladder Cancer: In Silico Profiling of Expression, Tumor–Immune Interactions, and Prognostic Impact
<i>Background and Objectives:</i> Siglec-XII, encoded by SIGLEC12, is a unique sialic acid-binding immunoglobulin-like lectin. It lacks a highly conserved R122 residue for sialic acid recognition in humans. Although it is upregulated in bladder cancer (BCa), its role in tumorigenesis remains largely...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2025-10-01
|
| Schriftenreihe: | Medicina |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1648-9144/61/11/1894 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|